3D0E

Crystal structure of human Akt2 in complex with GSK690693


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.246 
  • R-Value Work: 0.206 
  • R-Value Observed: 0.208 

wwPDB Validation 3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.

Heerding, D.A.Rhodes, N.Leber, J.D.Clark, T.J.Keenan, R.M.Lafrance, L.V.Li, M.Safonov, I.G.Takata, D.T.Venslavsky, J.W.Yamashita, D.S.Choudhry, A.E.Copeland, R.A.Lai, Z.Schaber, M.D.Tummino, P.J.Strum, S.L.Wood, E.R.Duckett, D.R.Eberwein, D.Knick, V.B.Lansing, T.J.McConnell, R.T.Zhang, S.Minthorn, E.A.Concha, N.O.Warren, G.L.Kumar, R.

(2008) J Med Chem 51: 5663-5679

  • DOI: 10.1021/jm8004527
  • Primary Citation of Related Structures:  
    3D0E

  • PubMed Abstract: 
  • Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhibitors of AKT kinase activity might be useful as monot ...

    Overexpression of AKT has an antiapoptotic effect in many cell types, and expression of dominant negative AKT blocks the ability of a variety of growth factors to promote survival. Therefore, inhibitors of AKT kinase activity might be useful as monotherapy for the treatment of tumors with activated AKT. Herein, we describe our lead optimization studies culminating in the discovery of compound 3g (GSK690693). Compound 3g is a novel ATP competitive, pan-AKT kinase inhibitor with IC 50 values of 2, 13, and 9 nM against AKT1, 2, and 3, respectively. An X-ray cocrystal structure was solved with 3g and the kinase domain of AKT2, confirming that 3g bound in the ATP binding pocket. Compound 3g potently inhibits intracellular AKT activity as measured by the inhibition of the phosphorylation levels of GSK3beta. Intraperitoneal administration of 3g in immunocompromised mice results in the inhibition of GSK3beta phosphorylation and tumor growth in human breast carcinoma (BT474) xenografts.


    Organizational Affiliation

    Oncology Center of Excellence for Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, USA. dirk.a.heerding@gsk.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
RAC-beta serine/threonine-protein kinaseAB335Homo sapiensMutation(s): 1 
Gene Names: AKT2
EC: 2.7.11.1
Find proteins for P31751 (Homo sapiens)
Explore P31751 
Go to UniProtKB:  P31751
NIH Common Fund Data Resources
PHAROS  P31751
Protein Feature View
Expand
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
G93
Query on G93

Download CCD File 
A, B
4-{2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methylbut-3 -yn-2-ol
C21 H27 N7 O3
KGPGFQWBCSZGEL-ZDUSSCGKSA-N
 Ligand Interaction
Modified Residues  1 Unique
IDChainsTypeFormula2D DiagramParent
TPO
Query on TPO
A,BL-PEPTIDE LINKINGC4 H10 N O6 PTHR
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
G93IC50:  1.7000000476837158   nM  BindingDB
G93IC50:  0.4000000059604645   nM  BindingDB
G93IC50:  2   nM  BindingDB
G93Kd:  2.200000047683716   nM  BindingDB
G93IC50:  13   nM  Binding MOAD
G93Ki :  4   nM  PDBBind
G93Ki:  4   nM  BindingDB
G93IC50:  0.6000000238418579   nM  BindingDB
G93IC50:  13   nM  BindingDB
G93Kd:  2.0999999046325684   nM  BindingDB
G93Ki:  1   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 0.246 
  • R-Value Work: 0.206 
  • R-Value Observed: 0.208 
  • Space Group: P 32
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 116.489α = 90
b = 116.489β = 90
c = 45.119γ = 120
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
REFMACrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2008-10-21
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Advisory, Version format compliance
  • Version 1.2: 2016-12-28
    Changes: Non-polymer description
  • Version 1.3: 2017-10-25
    Changes: Refinement description